HEATHER DOOLITTLE: Open Payments
NPI 1629643317 · AUBURN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,593 in 55 payments from 21 companies in 2025. Trend: 2023 $2,526 · 2024 $1,664 · 2025 $1,593
Food & beverage: $1,593
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $253 |
| Axsome Therapeutics, Inc. | 7 | $251 |
| PFIZER INC. | 4 | $168 |
| Otsuka America Pharmaceutical, Inc. | 2 | $130 |
| Pharmacosmos Therapeutics Inc. | 1 | $125 |
| Lilly USA, LLC | 4 | $123 |
| Novo Nordisk Inc | 7 | $112 |
| ABBVIE INC. | 5 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Abbott Laboratories | 2 | $44 |
Products named: Auvelity, BREZTRI, NURTEC ODT, REXULTI, MONOFERRIC, AIRSUPRA, ZEPBOUND, CAPLYTA.
Industry payments across IN — which companies pay providers there.
